Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
11/09/2026 12:14
BRIEF-Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization Sept 11 (Reuters) - Shilpa Medicare Ltd SHME.NS:
RECEIVES FINAL SEC APPROVAL FOR OERIS MARKETING AUTHORIZATION
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026